| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 3 | |
| #2 | EPO (European Patent Office) | 3 | |
| #3 | Israel | 3 | |
| #4 | WIPO (World Intellectual Property Organization) | 3 | |
| #5 | Brazil | 1 | |
| #6 | Canada | 1 | |
| #7 | China | 1 | |
| #8 | Republic of Korea | 1 | |
| #9 | Mexico | 1 | |
| #10 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Heterocyclic compounds | |
| #2 | Therapeutic chemical compounds | |
| #3 | Medical preparations |
| # | Name | Total Patents |
|---|---|---|
| #1 | Schwartz Brett | 13 |
| #2 | Nelms Keats | 13 |
| #3 | Banwell Martin | 10 |
| #4 | Jackson Colin | 10 |
| #5 | Hammond Edward | 10 |
| #6 | Natoli Riccardo | 3 |
| #7 | Brett Schwartz | 2 |
| #8 | Keats Nelms | 2 |
| #9 | Martin Banwell | 2 |
| #10 | Edward Hammond | 2 |
| Publication | Filing date | Title |
|---|---|---|
| CA3046997A1 | Heparanase inhibitors and use thereof | |
| AU2017376818A1 | Heparanase inhibitors and use thereof | |
| US2019345143A1 | Heparanase inhibitors and use thereof | |
| EP3554505A1 | Methods of treating ocular disorders |